Skip survey header

2018 Clinical Conference Evaluation & Post Test-Enduring Materials Format: Med Mgmt of DVTs and Clotting Disorders

Evaluation

Sept 18, 2018 - Evaluation - Med Mgmt of DVTs and Clotting Disorders - Robert Robles, MD
Estimated Time to complete the activity is 45 minutes. Activity and content expires: Sept 18, 2021
Statement of disclosure: The planners and faculty for this activity have no relevant financial relationships with commercial interests. No others individuals involved in the planning or presentation of this activity have any relevant financial relationships with commercial interests to disclose.
Accreditation Statement: John Muir Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
Credit Designation Statement: John Muir Health designates this enduring material for a maximum of one (.75) AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
Minimum level of achievement:   Must score 75% correct on posttest and complete the statement of how you will improve your practice after participation is mandatory.
JMH Internet Policy: https://www.johnmuirhealth.com/website-privacy-policy1.html
 
Please complete and return this evaluation form in order to receive a maximum of .75 AMA PRA Category 1 Credit™ for this session
1. Physician Info
This question requires a valid date format of MM/DD/YYYY.
calendar
3. As a result of attending this CME activity, which of these do you plan to implement and/or change in your practice? *This question is required.
Space Cell DefinitelyMaybeNo Change
Differentiate between older and newer options for the management of DVTs and clotting disorders
Formulate and communicate treatment plans for the management of medically and socially complex patients
Apply best practice strategies to overcome co-morbidities in medically and socially complex patients
Apply tips and tricks for navigating Epic.
Utilize EBM Guidelines for a multitude of conditions that are encountered in primary care
Utilize Patient Centered Care skill to help patients become better informed and more involved in their health care decisions.
9. Was their evidence of commercial bias in this session? ​
10. Compared to warfarin, DOACs have been shown to have a lower overall bleeding risk, not need monitoring, and have less drug-drug interactions. 
11. ACCP recommends stopping therapy after 3 months in a patient with a first unprovoked proximal DVT of the leg or PE and who has low or moderate bleeding risk. 
12. ACCP recommends stopping therapy after 3 months in a patient with a first unprovoked proximal DVT of the leg or PE and who has low or moderate bleeding risk. 
13. In the setting of an acute clot in a patient started on anticoagulation, if there is an indication, a full hypercoagulable work up (factor V leiden and prothrombin gene mutations, protein C/S and ATIII levels, and APLA testing) can and should be initiated.